Botulinum therapy in treatment of patients with rosacea

Abstract

The article deals epidemiology, pathomorphological picture, trigger factors of development, peculiarities of treatment with the use of botulinum therapy for rosacea. A clinical case is presented.Purpose of the article. Consider the pathogenesis of rosacea, investigate the molecular mechanism by which botulinum toxin improves the condition in rosacea.Material and methods. The article presents clinical examples of botulinum therapy in the treatment of patients with rosacea. The epidemiology, pathomorphological picture, developmental trigger factors, diagnostic features and approaches to the treatment of rosacea in modern conditions are considered.Results. Case study results show that intradermal botulinum toxin injections are safe and effective in reducing erythema and flushing in rosacea.Conclusions. Botulinum therapy – may be an alternative therapy for patients with refractory to standard treatment of persistent erythema. The effect after botulinum therapy lasts for 2–4 months. Further research is needed on the effcacy and safety of this technique in patients with different subtypes of rosacea, including those with a combination of subtypes.